-
Tytuł:
-
Budget impact analysis of breast cancer screening in Italy: The role of new technologies.
-
Autorzy:
-
Foglia, Emanuela
Marinelli, Sissi
Garagiola, Elisabetta
Ferrario, Lucrezia
Depretto, Catherine
Cartia, Francesco
Ferranti, Claudio
Porazzi, Emanuele
Scaperrotta, Gianfranco
-
Temat:
-
BREAST tumor diagnosis
MAMMOGRAMS
BREAST tumors
BUDGET
CANCER patients
CANCER patient medical care
COMPARATIVE studies
ECONOMIC aspects of diseases
REPORTING of diseases
FORECASTING
HOSPITALS
LIFE expectancy
MEDICAL care
MEDICAL care use
MEDICAL care costs
NATIONAL health services
SCIENTIFIC observation
POLICY sciences
QUALITY assurance
TECHNOLOGY
TIME
ULTRASONIC imaging
WOMEN'S health
COST analysis
GOVERNMENT programs
HUMAN services programs
HEALTH & social status
DESCRIPTIVE statistics
EARLY detection of cancer
-
Źródło:
-
Health Services Management Research; May2020, Vol. 33 Issue 2, p66-75, 10p, 6 Charts, 1 Graph
-
Terminy geograficzne:
-
ITALY
-
Although mammography screening significantly reduces breast cancer mortality, women could present different morphological characteristics that do not allow the correct vision of their breasts and the detection of cancer, resulting in a delay of diagnosis and an increase in the risk of mortality. The present study aims at analyzing potential areas of improvement of the current screening programs and then hypothesizing alternative technologies to use within the diagnostic phase, from an economic point of view. A Budget Impact Analysis approach was implemented, considering the Italian National Healthcare Service perspective, and representing the healthcare expenditure evolution, over three years. In the Budget Impact Analysis model, two distinct phases of the screening programs were considered: (1) the screening/diagnosis phase and (2) the phase related to cancer care and treatments of patients. The results provide clinicians and policy makers with a rational method to forecast economic resources in the screening programs in a general context of limited resources. In particular, results of the Budget Impact Analysis showed that, while the introduction of the ABUS InveniaTM technology into the screening programs would lead to an increase in the screening phase expenditure, it would generate an economic advantage related to the patients treatment and care. [ABSTRACT FROM AUTHOR]
Copyright of Health Services Management Research is the property of Sage Publications, Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)